UCSD and the Department of Veterans Affairs Collaboration CARLSBAD, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — AVACEN Medical announced today that Dr. Francisco Cidral, ND, PhD’s ...

Fibromyalgia is a chronic condition that causes widespread pain all over the body, fatigue and poor sleep, and it often also causes problems with mood, memory and concentration. It affects about 2% of ...

Credit: Tonix Pharmaceuticals. Tonmya is a once-daily sublingual tablet of cyclobenzaprine HCI taken at bedtime for the treatment of fibromyalgia. Clinical trials have demonstrated that Tonmya reduces ...

Please provide your email address to receive an email when new articles are posted on . Efforts to better understand and treat fibromyalgia are ongoing and multifaceted, with an increased emphasis on ...

Fibromyalgia patients’ satisfaction with their treatment is predictable through consideration of pre-treatment, patient-specific factors, according to a study in the journal Clinical and Experimental ...

Many people with fibromyalgia describe the chronic condition as a "bad case of the flu that never goes away," because they have widespread pain, wake up with stiff muscles and experience brain fog, ...

ST. CLOUD, Minn. -- Imagine one of the worst pains you've ever felt in your life. Now imagine someone telling you it's all in your head. "It was extremely frustrating," said Karen Linnell, who was ...

Dear Doctors: I had muscle pain and exhaustion for two years, and no one could figure out what was wrong. A rheumatologist recently diagnosed me with fibromyalgia. I would appreciate any information ...

Tonmya is expected to be available in the fourth quarter of 2025. The Food and Drug Administration (FDA) has approved Tonmya ™ (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of ...

Pregabalin, known to many by its trade name, “Lyrica,” works well, when, well, it works. A recent review of clinical studies involving Lyrica for the treatment of fibromyalgia concluded that only a ...